Oncoinvent has published Phase 1 dosimetry data for Radspherin in [...]

Alamar Biosciences is expanding a partnership with the Alzheimer’s Disease [...]

Zilucoplan has been accepted for restricted use in NHS Scotland [...]

Grifols has completed patient follow-up in its Phase 3 SPARTA [...]

Novo Nordisk and AWS have launched a London co-innovation hub [...]

Almirall has entered a drug discovery collaboration with CrystalO to [...]

AstronauTx has exercised its option to acquire worldwide rights to [...]

A European consortium has validated a continuous manufacturing platform designed [...]

BioVie has reported topline results from a Phase 2 trial [...]

Biotech company LifeMine Therapeutics has raised $263 million to support [...]